# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Under the terms of the five-year contract, with options, KBR will provide its differentiated advisory and consultancy capabilit...
The Safety and Mission Assurance, Audits, Assessments, and Analysis (SA3) Services contract is a cost-plus-fixed-fee contract w...
KBR will have the opportunity to bid on task orders under the Medical Q Coded Support and Services Next Generation (MQS2-NG) co...
KBR (NYSE:KBR) and Sumitomo Chemical announced today that they have signed an alliance agreement to make KBR an exclusive licen...
UBS analyst Steven Fisher maintains KBR (NYSE:KBR) with a Buy and raises the price target from $68 to $77.
KBR (NYSE:KBR) announced today it has been awarded a contract by OCI Global (OCI) to design and deploy its proprietary operator...
Stifel analyst Bert Subin maintains KBR (NYSE:KBR) with a Buy and raises the price target from $83 to $84.